Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment.

The cancer cell metabolism or the Warburg effect discovery goes back to 1924 when, for the first time Otto Warburg observed, in contrast to the normal cells, cancer cells have different metabolism. With the initiation of high throughput technologies and computational systems biology, cancer cell metabolism renaissances and many attempts were performed to revise the Warburg effect. The development of experimental and analytical tools which generate high-throughput biological data including lots of information could lead to application of computational models in biological discovery and clinical medicine especially for cancer. Due to the recent availability of tissue-specific reconstructed models, new opportunities in studying metabolic alteration in various kinds of cancers open up. Structural approaches at genome-scale levels seem to be suitable for developing diagnostic and prognostic molecular signatures, as well as in identifying new drug targets. In this review, we have considered these recent advances in structural-based analysis of cancer as a metabolic disease view. Two different structural approaches have been described here: topological and constraint-based methods. The ultimate goal of this type of systems analysis is not only the discovery of novel drug targets but also the development of new systems-based therapy strategies.

[1]  Hiroaki Kitano,et al.  Biological robustness , 2008, Nature Reviews Genetics.

[2]  Nagasuma R. Chandra,et al.  Flux balance analysis of biological systems: applications and challenges , 2009, Briefings Bioinform..

[3]  Michael Hucka,et al.  LibSBML: an API Library for SBML , 2008, Bioinform..

[4]  O. Reséndis-Antonio,et al.  Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect , 2010, PloS one.

[5]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[6]  E. Ruppin,et al.  Predicting selective drug targets in cancer through metabolic networks , 2011, Molecular systems biology.

[7]  Bernhard O. Palsson,et al.  Metabolite coupling in genome-scale metabolic networks , 2006, BMC Bioinformatics.

[8]  Richard Morphy,et al.  Fragments, network biology and designing multiple ligands. , 2007, Drug discovery today.

[9]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[10]  Intawat Nookaew,et al.  The RAVEN Toolbox and Its Use for Generating a Genome-scale Metabolic Model for Penicillium chrysogenum , 2013, PLoS Comput. Biol..

[11]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[12]  Bernhard O. Palsson,et al.  Metabolic Reconstruction and Modeling of Nitrogen Fixation in Rhizobium etli , 2007, PLoS Comput. Biol..

[13]  Falk Schreiber,et al.  VANTED: A system for advanced data analysis and visualization in the context of biological networks , 2006, BMC Bioinformatics.

[14]  Gavin MacBeath,et al.  Linear combinations of docking affinities explain quantitative differences in RTK signaling , 2009, Molecular systems biology.

[15]  D. Lauffenburger,et al.  A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis , 2005, Science.

[16]  Lin He,et al.  Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study , 2011, PLoS Comput. Biol..

[17]  T. Robak,et al.  Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. , 2006, Current medicinal chemistry.

[18]  Igor Goryanin,et al.  Compartmentalization of the Edinburgh Human Metabolic Network , 2010, BMC Bioinformatics.

[19]  Marcel J. T. Reinders,et al.  Predicting Metabolic Fluxes Using Gene Expression Differences As Constraints , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[20]  T. Dandekar,et al.  New trends in pharmacogenomic strategies against resistance development in microbial infections. , 2008, Pharmacogenomics.

[21]  D. Fell,et al.  Fat synthesis in adipose tissue. An examination of stoichiometric constraints. , 1986, The Biochemical journal.

[22]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[23]  P. Park.  ChIP–seq: advantages and challenges of a maturing technology , 2009, Nature Reviews Genetics.

[24]  H. Kitano.  A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.

[25]  C. Gille,et al.  HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.

[26]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[27]  Felix Tretter,et al.  Systems biology in psychiatric research: from complex data sets over wiring diagrams to computer simulations. , 2012, Methods in molecular biology.

[28]  Cristian R. Munteanu,et al.  MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae. , 2011, Journal of proteome research.

[29]  Jennifer L. Reed,et al.  Shrinking the Metabolic Solution Space Using Experimental Datasets , 2012, PLoS Comput. Biol..

[30]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[31]  Jason A. Papin,et al.  Functional integration of a metabolic network model and expression data without arbitrary thresholding , 2011, Bioinform..

[32]  B. Palsson,et al.  Transcriptional regulation in constraints-based metabolic models of Escherichia coli Covert , 2002 .

[33]  D. Lauffenburger,et al.  Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells , 2008, Molecular Pharmacology.

[34]  S. Lewandowsky.  PLOS ONE 2013 , 2015 .

[35]  Bernhard O. Palsson,et al.  A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1 , 2010, BMC Systems Biology.

[36]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[37]  Nathan D. Price,et al.  Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE , 2012, BMC Systems Biology.

[38]  E. Ruppin,et al.  Multiple knockout analysis of genetic robustness in the yeast metabolic network , 2006, Nature Genetics.

[39]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.

[40]  Rod K. Nibbe,et al.  Discovery and Scoring of Protein Interaction Subnetworks Discriminative of Late Stage Human Colon Cancer*S , 2009, Molecular & Cellular Proteomics.

[41]  Bernhard O. Palsson,et al.  Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..

[42]  Mehmet Koyutürk,et al.  An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer , 2010, PLoS Comput. Biol..

[43]  Xiaobo Zhou,et al.  Predicting enzyme targets for cancer drugs by profiling human Metabolic reactions in NCI-60 cell lines , 2010, BMC Bioinformatics.

[44]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[45]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[46]  Albert-László Barabási,et al.  The Activity Reaction Core and Plasticity of Metabolic Networks , 2005, PLoS Comput. Biol..

[47]  Miguel A Esteban,et al.  HIF, a missing link between metabolism and cancer , 2005, Nature Medicine.

[48]  J. Reed,et al.  RELATCH: relative optimality in metabolic networks explains robust metabolic and regulatory responses to perturbations , 2012, Genome Biology.

[49]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[50]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[51]  Michael Hucka,et al.  SBMLToolbox: an SBML toolbox for MATLAB users , 2006, Bioinform..

[52]  Gerhard Reinelt,et al.  PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways , 2010, Bioinform..

[53]  Falk Schreiber,et al.  Analysis of Biological Networks , 2008 .

[54]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[55]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[56]  Jason A. Papin,et al.  Metabolic network reconstruction of Chlamydomonas offers insight into light-driven algal metabolism , 2011, Molecular systems biology.

[57]  R. Gillies,et al.  Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors , 2005 .

[58]  I. Karimi,et al.  Elucidation of metabolism in hybridoma cells grown in fed‐batch culture by genome‐scale modeling , 2009, Biotechnology and bioengineering.

[59]  Gerhard Reinelt,et al.  Analyzing the regulation of metabolic pathways in human breast cancer , 2009, BMC Medical Genomics.

[60]  Jason A. Papin,et al.  Metabolic Network Analysis of Pseudomonas aeruginosa during Chronic Cystic Fibrosis Lung Infection , 2010, Journal of bacteriology.

[61]  Steffen Klamt,et al.  Structural and functional analysis of cellular networks with CellNetAnalyzer , 2007, BMC Systems Biology.

[62]  An-Ping Zeng,et al.  Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms , 2003, Bioinform..

[63]  I. Nookaew,et al.  Fifteen years of large scale metabolic modeling of yeast: developments and impacts. , 2012, Biotechnology advances.

[64]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[65]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[66]  B. Palsson,et al.  A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .

[67]  J. Nielsen,et al.  Integration of gene expression data into genome-scale metabolic models. , 2004, Metabolic engineering.

[68]  C. Galmarini,et al.  Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. , 2008, Current medicinal chemistry.

[69]  Michael C. Jewett,et al.  Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p , 2009, Proceedings of the National Academy of Sciences.

[70]  Jason A. Papin,et al.  Integration of expression data in genome-scale metabolic network reconstructions , 2012, Front. Physio..

[71]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir , 2011, PLoS Comput. Biol..

[72]  Ali Masoudi-Nejad,et al.  Controllability in Cancer Metabolic Networks According to Drug Targets as Driver Nodes , 2013, PloS one.

[73]  Markus J. Herrgård,et al.  Integrated analysis of regulatory and metabolic networks reveals novel regulatory mechanisms in Saccharomyces cerevisiae. , 2006, Genome research.

[74]  U. Alon.  Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.

[75]  E. Ruppin,et al.  Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.

[76]  Jason A. Papin,et al.  A metabolic network approach for the identification and prioritization of antimicrobial drug targets. , 2012, Trends in microbiology.

[77]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[78]  J. Doyle,et al.  Bow Ties, Metabolism and Disease , 2022 .

[79]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[80]  B. Palsson,et al.  Metabolic systems biology , 2009, Encyclopedia of Complexity and Systems Science.

[81]  B. Palsson,et al.  Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.

[82]  Desmond S. Lun,et al.  Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production , 2009, PLoS Comput. Biol..

[83]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[84]  Andrzej M. Kierzek,et al.  SurreyFBA: a command line tool and graphics user interface for constraint-based modeling of genome-scale metabolic reaction networks , 2011, Bioinform..

[85]  Douglas A. Lauffenburger,et al.  Common effector processing mediates cell-specific responses to stimuli , 2007, Nature.

[86]  A. Barabasi,et al.  Predicting synthetic rescues in metabolic networks , 2008, Molecular systems biology.

[87]  Kenneth J. Kauffman,et al.  Advances in flux balance analysis. , 2003, Current opinion in biotechnology.

[88]  S Gail Eckhardt,et al.  NMR-based metabolomics: translational application and treatment of cancer. , 2007, Current opinion in molecular therapeutics.

[89]  Philip E. Bourne,et al.  Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..

[90]  Markus J. Herrgård,et al.  Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.

[91]  Adam M. Feist,et al.  The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.

[92]  Mohita Upadhyay,et al.  The Warburg effect: insights from the past decade. , 2013, Pharmacology & therapeutics.

[93]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[94]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[95]  Francisco J. Planes,et al.  Path finding methods accounting for stoichiometry in metabolic networks , 2011, Genome Biology.

[96]  O. Sporns,et al.  Identification and Classification of Hubs in Brain Networks , 2007, PloS one.

[97]  B. Palsson,et al.  Combining pathway analysis with flux balance analysis for the comprehensive study of metabolic systems. , 2000, Biotechnology and bioengineering.

[98]  Peter A Vanrolleghem,et al.  Modeling with a view to target identification in metabolic engineering: A critical evaluation of the available tools , 2010, Biotechnology progress.

[99]  Z. Hall.  Cancer , 1906, The Hospital.

[100]  H. Nelson,et al.  Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. , 2001, The Journal of allergy and clinical immunology.

[101]  Gregg B Whitworth,et al.  An introduction to microarray data analysis and visualization. , 2010, Methods in enzymology.

[102]  B. Palsson,et al.  Large-scale in silico modeling of metabolic interactions between cell types in the human brain , 2010, Nature Biotechnology.

[103]  Natapol Pornputtapong,et al.  Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..

[104]  Roded Sharan,et al.  Genome-Scale Metabolic Modeling Elucidates the Role of Proliferative Adaptation in Causing the Warburg Effect , 2011, PLoS Comput. Biol..

[105]  Ernesto S. Nakayasu,et al.  Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation , 2012, Molecular systems biology.

[106]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[107]  Aarash Bordbar,et al.  iAB-RBC-283: A proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states , 2011, BMC Systems Biology.

[108]  K. Sachs,et al.  Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data , 2005, Science.

[109]  Roland Eils,et al.  Identifying essential genes in bacterial metabolic networks with machine learning methods , 2010, BMC Systems Biology.

[110]  D. Leroith,et al.  The Link between the Metabolic Syndrome and Cancer , 2011, International journal of biological sciences.

[111]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[112]  Eric K. Gupta,et al.  Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia. , 2002, Heart disease.

[113]  T. Seyfried,et al.  Cancer as a metabolic disease , 2010, Nutrition & metabolism.

[114]  Pei Yee Ho,et al.  Multiple High-Throughput Analyses Monitor the Response of E. coli to Perturbations , 2007, Science.

[115]  Yi Zhou,et al.  Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited , 2010, BMC Systems Biology.